|
Cullinan Therapeutics Common
(CGEM)
|
13.2 |
$93M |
|
7.6M |
12.18 |
|
Crinetics Pharmaceuticals Common
(CRNX)
|
4.5 |
$32M |
|
617k |
51.13 |
|
Edgewise Therapeutics Common
(EWTX)
|
4.1 |
$29M |
|
1.1M |
26.70 |
|
Insmed Incorporated Common
(INSM)
|
3.8 |
$27M |
|
390k |
69.04 |
|
Natera Common
(NTRA)
|
3.6 |
$25M |
|
161k |
158.30 |
|
Mirum Pharmaceuticals Common
(MIRM)
|
3.5 |
$24M |
|
590k |
41.35 |
|
Disc Medicine Common
(IRON)
|
3.1 |
$22M |
|
346k |
63.40 |
|
Lantheus Holdings Common
(LNTH)
|
3.0 |
$21M |
|
236k |
89.46 |
|
Zai Lab Common
(ZLAB)
|
3.0 |
$21M |
|
800k |
26.19 |
|
Avidity Biosciences Common
(RNA)
|
2.9 |
$20M |
|
703k |
29.08 |
|
Iovance Biotherapeutics Common
(IOVA)
|
2.8 |
$20M |
|
2.7M |
7.40 |
|
PTC Therapeutics Common
(PTCT)
|
2.8 |
$20M |
|
435k |
45.14 |
|
Wave Life Sciences PTE Common
(WVE)
|
2.6 |
$18M |
|
1.5M |
12.37 |
|
Scholar Rock Holding Corp. Common
(SRRK)
|
2.6 |
$18M |
|
416k |
43.22 |
|
Moonlake Immunotherapeutics Class A Ord
(MLTX)
|
2.4 |
$17M |
|
315k |
54.15 |
|
Olema Pharmaceuticals Common
(OLMA)
|
2.4 |
$17M |
|
2.9M |
5.83 |
|
Ultragenyx Pharmaceutical Common
(RARE)
|
2.3 |
$17M |
|
391k |
42.07 |
|
Context Therapeutics Common
(CNTX)
|
2.2 |
$15M |
|
15M |
1.05 |
|
Guardant Health Common
(GH)
|
2.0 |
$14M |
|
453k |
30.55 |
|
Revolution Medicines Common
(RVMD)
|
1.9 |
$14M |
|
314k |
43.74 |
|
iTeos Therapeutics Common
|
1.9 |
$13M |
|
1.7M |
7.68 |
|
Cartesian Therapeutics Common
(RNAC)
|
1.8 |
$13M |
|
721k |
17.91 |
|
Rocket Pharmaceuticals Common
(RCKT)
|
1.8 |
$13M |
|
1.0M |
12.57 |
|
Akero Therapeutics Common
(AKRO)
|
1.8 |
$13M |
|
461k |
27.82 |
|
Trevi Therapeutics Common
(TRVI)
|
1.8 |
$13M |
|
3.1M |
4.12 |
|
Twist Bioscience Corp Common
(TWST)
|
1.8 |
$12M |
|
268k |
46.47 |
|
Compass Therapeutics Common
(CMPX)
|
1.8 |
$12M |
|
8.6M |
1.45 |
|
Janux Therapeutics Common
(JANX)
|
1.7 |
$12M |
|
230k |
53.54 |
|
Replimune Group Common
(REPL)
|
1.6 |
$12M |
|
950k |
12.11 |
|
Nuvation Bio Common
(NUVB)
|
1.6 |
$11M |
|
4.2M |
2.66 |
|
Vera Therapeutics Class A Ord
(VERA)
|
1.5 |
$11M |
|
258k |
42.29 |
|
Ideaya Biosciences Common
(IDYA)
|
1.5 |
$11M |
|
414k |
25.70 |
|
Relay Therapeutics Common
(RLAY)
|
1.3 |
$9.3M |
|
2.3M |
4.12 |
|
United Therapeutics Corp. Common
(UTHR)
|
1.2 |
$8.1M |
|
23k |
352.84 |
|
Arcturus Therapeutics Holdings Common
(ARCT)
|
1.1 |
$7.8M |
|
460k |
16.97 |
|
Xenon Pharmaceuticals Common
(XENE)
|
1.1 |
$7.7M |
|
197k |
39.20 |
|
Stoke Therapeutics Common
(STOK)
|
1.1 |
$7.6M |
|
686k |
11.03 |
|
Aquestive Therapeutics Common
(AQST)
|
0.8 |
$5.7M |
|
1.6M |
3.56 |
|
Axsome Therapeutics Common
(AXSM)
|
0.6 |
$4.2M |
|
50k |
84.61 |
|
Sutro Biopharma Common
|
0.6 |
$4.0M |
|
2.2M |
1.84 |
|
Werewolf Therapeutics Common
(HOWL)
|
0.5 |
$3.5M |
|
2.4M |
1.48 |
|
Design Therapeutics Common
(DSGN)
|
0.5 |
$3.5M |
|
560k |
6.17 |
|
Zentalis Pharmaceuticals Common
(ZNTL)
|
0.5 |
$3.4M |
|
1.1M |
3.03 |
|
Veru Common
|
0.4 |
$2.8M |
|
4.3M |
0.65 |
|
Adaptimmune Therapeutics Sponsored ADR
(ADAPY)
|
0.4 |
$2.7M |
|
5.1M |
0.54 |
|
ALX Oncology Holdings Common
(ALXO)
|
0.3 |
$2.3M |
|
1.4M |
1.67 |
|
Repare Therapeutics Common
|
0.2 |
$1.6M |
|
1.2M |
1.31 |